Literature DB >> 3159387

Immunoreactive atrial natriuretic factor (IR-ANF) in human plasma.

J Gutkowska, M Bourassa, D Roy, G Thibault, R Garcia, M Cantin, J Genest.   

Abstract

A direct radioimmunoassay for ANF in human plasma was developed. A synthetic alpha-human atrial peptide (Ser 99-Tyr 126) was used for preparation of the iodinated tracer and the standards. The sensitivity of the method is 1.9 pg/ml. Concentration of immunoreactive ANF (IR-ANF) in plasma of 59 clinically normal subjects was 65.3 +/- 2.5 pg/ml (mean +/- SE). In two patients who underwent atrial pacing an increase of about 100 percent in circulating IR-ANF was observed. IR-ANF was extracted from human plasma by Vycor glass and purified by HPLC. The main immunoreactive isolated peak contained a low molecular weight peptide.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3159387     DOI: 10.1016/0006-291x(85)91089-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  Effects of arotinolol on exercise capacity and humoral factors during exercise in normal subjects.

Authors:  T Mori; K Handa; Y Terao; H Tanaka; A Kiyonaga; M Shindo; A Matsunaga; J Sasaki; K Arakawa
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

Review 2.  Atrial natriuretic factor: a hormone secreted by the heart.

Authors:  D D Macchia
Journal:  Pharm Weekbl Sci       Date:  1987-12-11

3.  The interaction of plasma renin activity and plasma atrial natriuretic peptide in 21-hydroxylase deficiency patients.

Authors:  C M R Germano; M de Castro; J C Crescencio; L Gallo; J Antunes-Rodrigues; A C Moreira; L L K Elias
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

4.  Administration of slow-release nifedipine does not affect lactate threshold, hormone release during exercise, and quality of life in normal subjects.

Authors:  K Handa; T Mori; H Tanaka; Y Takada; A Matsunaga; A Kiyonaga; M Shindo; J Sasaki; K Arakawa
Journal:  Cardiovasc Drugs Ther       Date:  1992-02       Impact factor: 3.727

Review 5.  Biologically active atrial peptides.

Authors:  B J Ballerman; B M Brenner
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

6.  Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.

Authors:  A Clerico; G Iervasi; M G Del Chicca; M Emdin; S Maffei; M Nannipieri; L Sabatino; F Forini; C Manfredi; L Donato
Journal:  J Endocrinol Invest       Date:  1998-03       Impact factor: 4.256

7.  Increase in atrial natriuretic peptide in response to physical exercise.

Authors:  M Follenius; G Brandenberger
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

8.  The effect of hemorrhage and resuscitation on serum levels of immunoreactive atrial natriuretic factor.

Authors:  S R Shackford; C H Norton; M G Ziegler; K D Wilner
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

9.  Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP.

Authors:  A Sugawara; K Nakao; N Morii; T Yamada; H Itoh; S Shiono; Y Saito; M Mukoyama; H Arai; K Nishimura
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

10.  Influence of endogenous opioids on atrial natriuretic factor release during exercise in man.

Authors:  F Louisy; C Y Guezennec; M Lartigue; J C Aldigier; F X Galen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.